DYNF: Low Cost Active Factor ETF Now Outperforming The S&P 500 Index (NYSEARCA:DYNF)
This article was written byFollowThe Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background,...
Factor
Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline Transcript
Operator Welcome to the Regeneron conference call to discuss its Factor XI development program. My name is Shannon, and I...
